Skin Infection News and Research

RSS

Antibiotic-resistant MRSA all too common

Researchers in the U.S. say that methicillin-resistant Staphylococcus aureus or MRSA is the most common cause of skin and soft-tissue infections among patients presenting in emergency rooms across the country.

20 Aug 2006

Research offers new hope in helping elderly fight infections

Thousands of infections could be prevented each year in older people and hospital stays reduced following findings from two studies which show that imbalances in the immune systems of people aged over 65 make them more prone to illnesses like flu or bacterial infections as a result of cuts and falls.

21 Jul 2006

Microbes could represent the future of medicine

Not all bacteria are bad. In fact, beneficial microbes could represent the future of medicine, with the potential to treat a variety of diseases in humans and animals from diarrhea and eczema to gum disease and autoimmune disorders.

9 Jun 2006

New therapy proven to be effective in the treatment of MRS

Cosmetic considerations and a perceived lack of patent opportunities could be stopping the pharmaceutical and healthcare industries from investing in the development of a new therapy proven to be effective in the treatment of MRSA.

6 Apr 2006

Dramatic increase in antibiotic-resistant staph infections

Staph infections resistant to antibiotics, previously only associated with hospitalization or prior contact with the healthcare system, are now widespread in the community and coming home.

9 Mar 2006

Why more women die than men after heart bypass surgery

According to researchers, infections - including those acquired in hospitals, could explain why women die more frequently than men after heart bypass surgery and the explanations for this sex difference are controversial.

28 Feb 2006

Research points to a novel approach to treating serious Strep infections

Researchers at the University of California, San Diego (UCSD) School of Medicine have discovered that so-called flesh-eating "Strep" bacteria use a specific enzyme to break free of the body's immune system, a finding which could potentially lead to new treatments for serious infections in human patients.

24 Feb 2006

X-linked agammaglobulinemia

Individuals who have a rare genetic immune system disorder that prevents them from making antibodies nevertheless appear to be moderately healthy and lead productive lives, according to results of a study by investigators at St. Jude Children's Research Hospital.

18 Jan 2006

Protein finding could lead to new topical treatment for inflammatory diseases

A protein that undesirably shields a skin poxvirus from the immune system may become the key ingredient in a new topical treatment for inflammatory diseases, say medical researchers at the University of Illinois at Urbana-Champaign.

11 Jan 2006

MRSA prevalence may be due to over-prescribing and overuse of antibiotics

A dangerous drug-resistant bacterium is becoming more prevalent in many intensive care units, according to an article in the Feb. 1 issue of Clinical Infectious Diseases, now available online.

5 Jan 2006

2 million people carry drug-resistant bacteria in their noses

New research estimates that about 2 million people carry a strain of drug-resistant bacteria in their noses.

21 Dec 2005

Carbonic anhydrase and CO2 sensing during Cryptococcus neoformans growth, differentiation, and virulence

By using pathogenic fungi as model systems for understanding fungal diseases, two groups of researchers are reporting new work that offers insight into how carbon dioxide (CO2) governs the morphogenic changes that allow pathogenic fungi to survive in different environments and invade the human body

21 Nov 2005

Scientists discover why lung, but not skin, anthrax infections are lethal

Scientists from the Max Planck Institute for Infection Biology in Berlin discovered why lung, but not skin, anthrax infections are lethal. As reported in the newest issue of PloS Pathogen (November 2005) Neutrophils, a form of white blood cells, play a key role in anthrax infections.

13 Nov 2005

Wellcome Trust awards £8.1 million to tackle tropical diseases

The Wellcome Trust, one of the world’s largest medical charities, has awarded £8.1 million over 5 years to a team of six scientists at the University of Dundee to help discover new drugs to treat some of the world’s most neglected tropical diseases.

25 Oct 2005

New fungal defensin, plectasin, possesses as much power as penicillin

A peptide identified in a fungus found in northern European pine forests possesses as much power as penicillin as well as vancomycin, according to an international team of researchers.

12 Oct 2005

Increasingly virulent Staph infections

In a "Brief Report" in the 22 September 2005 issue of the New England Journal of Medicine, researchers at the University of Chicago describe three cases of rapidly progressive and ultimately fatal Staphylococcus aureus infections in small children.

26 Sep 2005

Study estimates Staphylococcus aureus infections cause 12,000 deaths, cost hospitals $9.5 billion

Staphylococcus aureus infections (S. aureus) create an enormous burden to hospitals by significantly increasing costs, length of patient stays and mortality rates, a Northwestern Memorial Hospital researcher found in the most comprehensive study to date, published today's Archives of Internal Medicine.

10 Aug 2005